Moreover, in vivo administration of H2S donors improved cognitive function and reduced tau-related neuropathology in transgenic AD mouse models, reinforcing the therapeutic promise of targeting H2S signalling in tauopathies and neurodegeneration. Here, MAPT is linked to Alzheimer disease.